
Tres Alchemix closes $4.4 million financing round
AI-driven biotechnology company Tres Alchemix has closed its $4.4 million Series A financing round, the company has announced. New funding will be used to accelerate the development of Tres Alchemix’s predictive AI platform and support the opening of a new laboratory at The Oxford Science Park, a hub of world-leading… Read More












